Brief Communications

• Early combination of bromocriptine and levodopa in the treatment of Parkinson's diseaseA 5‐year follow‐up

  U. K. Rinne

  • Abstract
  • Full Text (PDF)
• Symptoms of amaurosis fugax in atherosclerotic carotid artery disease

  James A. Goodwin, Philip B. Gorelick, Cathy M. Helgason

  • Abstract
  • Full Text (PDF)
• Parkinson's disease and myasthenia gravisAdverse effect of trihexyphenidyl on neuromuscular transmission

  S. Ueno, M. Takahashi, K. Kajiyama, N. Okahisa, T. Hazama, S. Yorifuji, S. Tarui

  • Abstract
  • Full Text (PDF)
• Regional nerve injury after intra‐arterial chemotherapy

  A. M. Castellanos, J. Peter Glass, W. K. Alfred Yung

  • Abstract
  • Full Text (PDF)
• Guillain‐Barré syndromeQuantitative measurement of plasma exchange therapy

  Markus Färkkilä, Esko Kinnunen, Erkki Haapanen, Matti Iivanainen

  • Abstract
  • Full Text (PDF)
• Cranial magnetic resonance imaging in the evaluation of myelopathy of undetermined etiology

  Robert M. Miska, Kathleen W. Pojunas, Michael P. McQuillen

  • Abstract
  • Full Text (PDF)
• Retrograde transport and differential accumulation of serum proteins in motor neuronsImplications for motor neuron diseases

  Teiji Yamamoto, Yum Iwasaki, Hidehiko Konno, Hideaki Iizuka, Jie-Xu Zhao

  • Abstract
  • Full Text (PDF)
• IgG synthesis rate in evaluation of multiple sclerosis in a community hospital

  Eric L. Matteson, David G. Flagler, Bruce W. Mesara

  • Abstract
  • Full Text (PDF)
• Dexamethasone suppression test abnormalities in multiple sclerosisRelation to ACTH therapy

  Anthony T. Reder, Martin T. Lowy, Herbert Y. Meltzer, Jack P. Antel

  • Abstract
  • Full Text (PDF)
• Oligoclonal IgG in tears

  P. K. Coyle, Patrick Sibony, Cynthia Johnson

  • Abstract
  • Full Text (PDF)
• 3–0‐methyldopa and motor fluctuations in Parkinson's disease

  G. Fabbrini, J. L. Juncos, M. M. Mouradian, C. Serrati, T. N. Chase

  • Abstract
  • Full Text (PDF)
• Congenital myopathy with type II muscle fiber hypoplasia

  M. Yoshioka, S. Kuroki, K. Ohkura, Y. Itagaki, K. Saida

  • Abstract
  • Full Text (PDF)
• Advanced Parkinson's diseaseUse of partial dopamine agonist, ciladopa

  A. Lieberman, G. Gopinathan, A. Neophytides, P. Pasternack, M. Goldstein

  • Abstract
  • Full Text (PDF)
• Phenelzine toxicity responsive to dantrolene

  Michael R. Verrilli, Virgilio D. Salanga, Walter E. Kozachuk, Michael Bennetts

  • Abstract
  • Full Text (PDF)
• Idiopathic normal pressure hydrocephalus and systemic hypertension

  Neill R. Graff-Radford, John C. Godersky

  • Abstract
  • Full Text (PDF)
• Physostigmine improves ECT‐induced memory disturbances

  Y. Levin, A. Elizur, A. D. Korczyn

  • Abstract
  • Full Text (PDF)
• Parkinson's disease and motor fluctuationsLong‐acting carbidopa/levodopa (CR‐4‐Sinemet)

  C. G. Goetz, C. M. Tanner, H. L. Klawans, K. M. Shannon, V. S. Carroll

  • Abstract
  • Full Text (PDF)
• NeurosarcoidosisCerebrospinal fluid lymphocyte subpopulations

  B. J. Stern, D. E. Griffin, R. A. Luke, A. Krumholz, C. J. Johns

  • Abstract
  • Full Text (PDF)
• Flunarizine‐ and cinnarizine‐induced extrapyramidal reactions

  F. Micheli, M. F. Pardal, M. Gatto, M. Torres, G. Paradiso, I. C. Parera, R. Giannaula

  • Abstract
  • Full Text (PDF)